510(k) K093346

BD GENEOHM MRSA ACP ASSAY by Bd Diagnostics (Geneohm Sciences, Inc.) — Product Code NQX

K093346 is an FDA 510(k) premarket notification submitted by Bd Diagnostics (Geneohm Sciences, Inc.) for the device "BD GENEOHM MRSA ACP ASSAY". The FDA issued a decision of Substantially Equivalent on Dec 15, 2009. The device falls under product code NQX (System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen), a Class II device regulated under 21 CFR 866.1640. Bd Diagnostics (Geneohm Sciences, Inc.) has 1 other 510(k) clearance on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 15, 2009
Date Received
Oct 26, 2009
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Device Class
Class II
Regulation Number
866.1640
Review Panel
MI
Submission Type
510(k)

A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of MRSA colonization status for the prevention and control of MRSA infections in healthcare settings.

Need the full FDA record for Bd Diagnostics (Geneohm Sciences, Inc.)? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K093346. Report a data issue: hello@regdatalab.com.